These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

718 related items for PubMed ID: 9669383

  • 1. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S, Tatsch K, Dähne I, Mager T, Scherer J, Hahn K.
    J Nucl Med; 1998 Jul; 39(7):1138-42. PubMed ID: 9669383
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sertindole and dopamine D2 receptor occupancy in comparison to risperidone, clozapine and haloperidol - a 123I-IBZM SPECT study.
    Kasper S, Tauscher J, Küfferle B, Barnas C, Hesselmann B, Asenbaum S, Podreka I, Brücke T.
    Psychopharmacology (Berl); 1998 Apr; 136(4):367-73. PubMed ID: 9600582
    [Abstract] [Full Text] [Related]

  • 5. [123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects.
    Schlösser R, Schlegel S, Hiemke C, Nickel O, Bockisch A, Rao ML, Hahn K.
    Psychiatry Res; 1997 Sep 29; 75(2):103-14. PubMed ID: 9351492
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.
    Bernardo M, Parellada E, Lomeña F, Catafau AM, Font M, Gómez JC, López-Carrero C, Gutiérrez F, Pavía J, Salamero M.
    Psychiatry Res; 2001 Aug 25; 107(2):87-97. PubMed ID: 11530275
    [Abstract] [Full Text] [Related]

  • 9. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
    Klemm E, Grünwald F, Kasper S, Menzel C, Broich K, Danos P, Reichmann K, Krappel C, Rieker O, Briele B, Hotze AL, Möller HJ, Biersack HJ.
    Am J Psychiatry; 1996 Feb 25; 153(2):183-90. PubMed ID: 8561197
    [Abstract] [Full Text] [Related]

  • 10. D2-dopamine receptor occupancy measured by IBZM-SPECT in relation to extrapyramidal side effects.
    Broich K, Grünwald F, Kasper S, Klemm E, Biersack HJ, Möller HJ.
    Pharmacopsychiatry; 1998 Sep 25; 31(5):159-62. PubMed ID: 9832346
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study.
    Meisenzahl EM, Dresel S, Frodl T, Schmitt GJ, Preuss UW, Rossmüller B, Tatsch K, Mager T, Hahn K, Möller HJ.
    J Psychopharmacol; 2000 Sep 25; 14(4):364-70. PubMed ID: 11198054
    [Abstract] [Full Text] [Related]

  • 13. Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels.
    Knable MB, Heinz A, Raedler T, Weinberger DR.
    Psychiatry Res; 1997 Sep 29; 75(2):91-101. PubMed ID: 9351491
    [Abstract] [Full Text] [Related]

  • 14. Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone.
    Küfferle B, Brücke T, Topitz-Schratzberger A, Tauscher J, Gössler R, Vesely C, Asenbaum S, Podreka I, Kasper S.
    Psychiatry Res; 1996 Nov 25; 68(1):23-30. PubMed ID: 9027930
    [Abstract] [Full Text] [Related]

  • 15. D2 dopamine receptor occupancy, risperidone plasma level and extrapyramidal motor symptoms in previously drug-free schizophrenic patients.
    Regenthal R, Kunstler U, Hesse S, Sabri O, Preiss R.
    Int J Clin Pharmacol Ther; 2005 Aug 25; 43(8):370-8. PubMed ID: 16119512
    [Abstract] [Full Text] [Related]

  • 16. IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol.
    Küfferle B, Tauscher J, Asenbaum S, Vesely C, Podreka I, Brücke T, Kasper S.
    Psychopharmacology (Berl); 1997 Oct 25; 133(4):323-8. PubMed ID: 9372530
    [Abstract] [Full Text] [Related]

  • 17. Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol.
    Tauscher J, Küfferle B, Asenbaum S, Tauscher-Wisniewski S, Kasper S.
    Psychopharmacology (Berl); 2002 Jun 25; 162(1):42-9. PubMed ID: 12107616
    [Abstract] [Full Text] [Related]

  • 18. Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine.
    Tuppurainen H, Kuikka JT, Viinamäki H, Husso M, Tiihonen J.
    Psychiatry Clin Neurosci; 2009 Aug 25; 63(4):529-37. PubMed ID: 19496999
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D2 receptor occupancy measured by single photon emission computed tomography with 123I-Iodobenzamide in chronic schizophrenia.
    Volk S, Maul FD, Hör G, Schreiner M, Weppner M, Holzmann T, Pflug B.
    Psychiatry Res; 1994 Jun 25; 55(2):111-8. PubMed ID: 10711799
    [Abstract] [Full Text] [Related]

  • 20. Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study.
    Busatto GF, Pilowsky LS, Costa DC, Ell PJ, Verhoeff NP, Kerwin RW.
    Psychopharmacology (Berl); 1995 Jan 25; 117(1):55-61. PubMed ID: 7536945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.